HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Non-Hodgkin's malignant lymphoma: reliability of "typing" using cyto-enzymatic markers. Comparison with immunological markers (author's transl)].

Abstract
Comparison between membrane markers and enzyme markers was made in 74 cases of non-Hodgkin's malignant lymphomas and a good correlation appears between both methods in order to distinct lymphomas into T and B origin. Enzyme markers are reliable and provide quickly made and easily interpretable documents. As far as T-lymphomas are concerned, three hydrolases namely acid phosphates e, acid esterase and B-glucuronidase give the same good results. As for B-lymphomas, a specific enzyme marker has to be found. Furthermore, typing of malignant lymphomas by enzymatic and/or immunologic methods appears to be quite better than from morphologic features such as convoluted or cleaved nuclei for example.
AuthorsC Micheau, A Bernard, E Pujade, D Belpomme, C Carlu, B Clausse
JournalLa Nouvelle presse medicale (Nouv Presse Med) Vol. 9 Issue 3 Pg. 167-70 (Jan 12 1980) ISSN: 0301-1518 [Print] France
Vernacular TitleLymphomes malins non hodgkiniens: fiabilité du "typage" par les marqueurs cyto-enzymatiques. Comparaison avec les marqueurs immunologiques.
PMID6965535 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Esterases
  • Alkaline Phosphatase
  • Acid Phosphatase
  • Glucuronidase
Topics
  • Acid Phosphatase (metabolism)
  • Alkaline Phosphatase (metabolism)
  • B-Lymphocytes (immunology)
  • Esterases (metabolism)
  • Glucuronidase (metabolism)
  • Humans
  • Lymphoma (diagnosis, enzymology, immunology)
  • Methods
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: